Expertize in both US and Global HEOR and Market Access strategy: launch readiness strategies, early compound development strategies, reimbursement and access strategies for HTA submissions Substantial multi-therapeutic experience (infectious disease, cardiovascular disease, oncology) in leading and conducting HEOR studies/projects including global value dossier (GVD), value proposition, objection handler, systematic literature review (SLR), indirect treatment comparisons, burden of illness, retrospective database/registry/chart review real-world studies, health economic evaluations including cost effectiveness, cost consequence and budget impact models, clinical trial-based analysis including medical resource utilization, cost impact and HTA-purposed analysis, PRO experience including PRO strategies, assessment, analysis and reporting in clinical development programs Proven statistical skills including regression-based modeling (linear, logistic and Cox), propensity score matching, reliability analysis, survival models, network meta-analysis, matching-adjusted indirect treatment comparison, and working knowledge of machine learning Excellent strategic thinking, problem-solving and collaborative skills Strong record of publications at peer-reviewed journals and presentations at congresses